pharmaceuticals

Thanks to an increased investment in pharmaceutical and biopharmaceuticals.

These firms have licences and are involved with self-operated pharmacies. 

India's weak IP laws could be an issue for drug manufacturers in Australia.

About 75% of APAC patients want more pharmaceutical regulations.

It is expected to grow at a CAGR of 5.7% over a ten-year forecast period. 

It also said that the annual medicine price review will affect medicine’s market growth trajectory. 

The majority of the country’s pharma manufacturing produces generic drugs.

This could help them in promoting indigenous medicines.

It has introduced a patent term extension for drugs.